Jong H S, Park Y I, Kim S, Sohn J H, Kang S H, Song S H, Bang Y J, Kim N K
Cancer Research Center, Seoul National University College of Medicine, Seoul, Korea.
Cancer. 1999 Aug 15;86(4):559-65.
Telomerase activation is thought to be essential for the stabilization of telomere length, through which immortalization and oncogenesis are achieved, but little is known about the regulation of telomerase in human gastric carcinoma cells.
A total of 27 primary gastric tumors, 29 cases of intestinal metaplasia, and 30 cases of normal mucosa, as well as 8 gastric carcinoma cell lines, were examined for the relation between telomerase activation and gastric carcinogenesis. Telomerase activity was detected by telomeric repeat amplification protocol, and the expression of each telomerase subunit was evaluated by Northern blot analysis or reverse transcriptase--polymerase chain reaction.
Telomerase activity was found in all 8 gastric carcinoma cell lines and in 25 of 27 gastric carcinoma tissue samples (93%), and weakly observed in 11 of 29 gastric intestinal metaplasia samples (38%). None of 30 normal gastric tissue samples displayed telomerase activity. The mRNA expression of human telomerase catalytic subunit (hTERT) was up-regulated in 26 of 26 tumor tissue samples (100%) and in 19 of 24 intestinal metaplasia (79%) in which telomerase activity was weak or negative. Normal gastric mucosa expressed the telomerase gene, albeit at low levels. In contrast to hTERT, human telomerase RNA component and human telomerase-associated protein expression did not parallel telomerase activity, which was independent of tumor stage and histology.
hTERT expression is up-regulated during an early stage in the carcinogenic process, and telomerase activation may be a critical step in gastric carcinogenesis.
端粒酶激活被认为对于端粒长度的稳定至关重要,通过端粒长度稳定可实现细胞永生化和肿瘤发生,但关于人胃癌细胞中端粒酶的调控知之甚少。
检测了27例原发性胃肿瘤、29例肠化生和30例正常黏膜组织,以及8种胃癌细胞系,以研究端粒酶激活与胃癌发生之间的关系。采用端粒重复序列扩增法检测端粒酶活性,通过Northern印迹分析或逆转录聚合酶链反应评估各端粒酶亚基的表达。
在所有8种胃癌细胞系和27例胃癌组织样本中的25例(93%)中检测到端粒酶活性,在29例胃肠化生样本中的11例(38%)中微弱检测到端粒酶活性。30例正常胃组织样本均未显示端粒酶活性。人端粒酶催化亚基(hTERT)的mRNA表达在26例肿瘤组织样本中的26例(100%)以及24例端粒酶活性弱或阴性的肠化生样本中的19例(79%)中上调。正常胃黏膜表达端粒酶基因,尽管表达水平较低。与hTERT相反,人端粒酶RNA组分和人端粒酶相关蛋白的表达与端粒酶活性不平行,端粒酶活性与肿瘤分期和组织学无关。
hTERT表达在致癌过程的早期阶段上调,端粒酶激活可能是胃癌发生中的关键步骤。